Embecta Corp.

NASDAQ: EMBCV · Real-Time Price · USD
33.33
-3.43 (-9.33%)
At close: Apr 01, 2022, 6:00 AM

Company Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.

Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.

The company primarily sells its products to wholesalers and distributors in the United States and internationally.

Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.

Embecta Corp.
Embecta Corp. logo
Country United States
IPO Date Mar 21, 2022
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,029
CEO n/a

Contact Details

Address:
1 Becton Drive
Franklin Lakes, New Jersey
United States
Website https://www.embecta.com

Stock Details

Ticker Symbol EMBCV
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001872789
CUSIP Number n/a
ISIN Number n/a
Employer ID 87-1583942
SIC Code 3841

Key Executives

No executives data available.

Latest SEC Filings

Date Type Title
Aug 14, 2025 SCHEDULE 13G/A [Amend] Filing
Aug 11, 2025 4 Filing
Aug 08, 2025 10-Q Quarterly Report
Aug 08, 2025 8-K Current Report
Jul 29, 2025 SCHEDULE 13G/A [Amend] Filing
Jul 18, 2025 SCHEDULE 13G/A [Amend] Filing
May 30, 2025 SD Filing
May 23, 2025 4 Filing
May 22, 2025 8-K Current Report
May 15, 2025 SCHEDULE 13G/A [Amend] Filing